PNH and aHUS Market Strategic Analysis of Revenue Growth and Market Potential
Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic Uremic Syndrome (aHUS) are rare, life-threatening disorders associated with dysregulation of the complement system. Increasing awareness of rare diseases, growing access to advanced diagnostic tools, and the development of targeted biologic therapies are significantly transforming the treatment landscape. Pharmaceutical companies...
0 Yorumlar 0 hisse senetleri 132 Views 0 önizleme